Product
LB64640
1 clinical trial
2 indications
Indication
ObesityIndication
HealthyClinical trial
Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Assess the Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of Compound LB54640 in Healthy Overweight and Obese SubjectsStatus: Completed, Estimated PCD: 2022-03-30